Keros Therapeutics, Inc. KROS
NASDAQ · United States · Health Technology
$11.36+0.10 (+0.89%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-03 | -1.45 | -1.34 | -8.2% | $0 | -100.0% | +1.8%$10.07→$10.25 |
| Q1 2026 | 2026-05-14 | -1.21 | -0.92 | -31.5% | — | — | -12.4%$11.99→$10.50 |
| Q4 2025 | 2026-03-04 | -0.86 | -0.45 | -91.1% | — | — | -12.6%$13.40→$11.71 |
| Q3 2025 | 2025-11-05 | -0.18 | -1.11 | +83.8% | — | — | +4.0%$15.55→$16.17 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.